Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dance for Children With Neurodevelopmental Disorders (Dance and NDDs)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04762290
Recruitment Status : Recruiting
First Posted : February 21, 2021
Last Update Posted : February 24, 2021
Sponsor:
Collaborator:
Health Resources and Services Administration (HRSA)
Information provided by (Responsible Party):
Rujuta B. Wilson, MD, University of California, Los Angeles

Brief Summary:

Motor impairments are prominent in individuals with autism spectrum disorder (ASD) and other neurodevelopment disorders, and these impairments often impact the individual's ability to engage in organized physical activity programs (OPA). While many studies have identified dance and creative movement to be retrospectively and anecdotally therapeutic, there remains a paucity of literature regarding outcomes associated with these programs, and specifically, their impact on (1) perceived and objective gross and fine motor skills, (2) perceived ability to succeed in related or divergent goals or tasks, (3) quality of life for affected individuals and their caregivers. (4) adaptive function, (5) social communication

This study explores the impact of organized dance and creative movement classes on children with neurodevelopmental disorders (ages 4-17) and their caregivers. Participants will complete a set of surveys and assessments designed to measure the above metrics (labeled 1, 2, and 3) at their first study visit. This initial assessment is expected to take place within two weeks prior to beginning the intervention (either a wait period or a series of 1-hour dance classes, which children will attend weekly for 10 weeks). The second and final study visit will consist of a similar set of surveys and assessments designed to measure the same metrics within the two weeks following completion of the dance class series. Participants who have completed the wait period at this point will then begin their set of 10 weekly dance classes. Expected duration of participation in the study is no longer than 14 weeks in total.


Condition or disease Intervention/treatment Phase
Neurodevelopmental Disorders Other: Dance Not Applicable

Detailed Description:

Motor impairments are prominent in individuals with autism spectrum disorder (ASD) and other neurodevelopment disorders, and these impairments often impact the individual's ability to engage in organized physical activity programs (OPA). While many studies have identified dance and creative movement to be retrospectively and anecdotally therapeutic, there remains a paucity of literature regarding outcomes associated with these programs, and specifically, their impact on (1) perceived and objective gross and fine motor skills, (2) perceived ability to succeed in related or divergent goals or tasks, (3) quality of life for affected individuals and their caregivers, (4) Adaptive function and socialization, (5) social communication.

This study explores the impact of organized dance and creative movement classes on children with neurodevelopmental disorders (ages 4-17) and their caregivers. Participants will complete a set of surveys and assessments designed to measure the above metrics (labeled 1, 2,3, 4, 5) at their first study visit. This initial assessment is expected to take place within two weeks prior to beginning the intervention (either a wait period or a series of 1-hour dance classes, which children will attend weekly for 10 weeks). The second and final study visit will consist of a similar set of surveys and assessments designed to measure the same metrics within the two weeks following completion of the dance class series. Participants who have completed the wait period at this point will then begin their set of 10 weekly dance classes.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: The study model is a waitlist control. There is an active group and a waitlist control group.
Masking: Single (Outcomes Assessor)
Masking Description: Certain direct outcome measure assessors will be masked
Primary Purpose: Other
Official Title: Dance for Children With Neurodevelopment Disorders: a Therapeutic Intervention to Improve Motor Ability, Quality of Life, Social Communication, Perceived Physical Competence, and Self-efficacy
Actual Study Start Date : January 31, 2021
Estimated Primary Completion Date : October 30, 2021
Estimated Study Completion Date : March 2, 2022

Arm Intervention/treatment
Active Comparator: Active Group
This group will receive the intervention in the first 10 weeks of the study. The intervention is a dance intervention that consists of a series of expressive movements.
Other: Dance
The intervention is a series of expressive dance movements.
Other Name: expressive movement

Waitlist Control
This group will receive the intervention in the second 10 weeks of the study (after the active group and after pre-post assessments in the first 10 weeks during the time of no intervention).
Other: Dance
The intervention is a series of expressive dance movements.
Other Name: expressive movement




Primary Outcome Measures :
  1. Movement Assessment Battery for Children Checklist [ Time Frame: 10 minutes ]
    Motor questionnaire

  2. Parenting Stress Index [ Time Frame: 20 minutes ]
    Measure of factors related to caregiver stress

  3. Vineland Adaptive Behavior Scale [ Time Frame: 45 minutes ]
    A measure of adaptive behavior and motor skills. The minimum value is 21 and maximum value is 140. Higher scores indicate a better outcome.

  4. Perceived Motor Competence Scale Parent Report [ Time Frame: 5 minutes ]
    A measure of perceived motor skills in the child. Higher scores indicate a better outcome. Scores are based on a likert scale of 1-4. The minimum score is 18 and the maximum score is 72.

  5. Perceived Motor Competence Scale Child Report [ Time Frame: 5 minutes ]
    A measure of perceived motor skills in the child (participant). Higher scores indicate a better outcome. The minimum score is 13 and the maximum score is 52.

  6. Brief Observation of Social Communication Change [ Time Frame: 10 minutes ]
    A videotaped observational coding of a child's social communication behavior.

  7. Children's Hope Scale [ Time Frame: 5 minutes ]
    A measure of children's self-perception of goal attainability. Lower scores indicate a worse outcome. The minimum score is 6 and the maximum score is 36.

  8. Pediatric Quality of Life Inventory [ Time Frame: 5 minutes ]
    Quality of life measures

  9. Piers Harris Self Concept Scale [ Time Frame: 15 minutes ]
    A measure of self abilities. Lower scores indicate a worse outcome. T-scores of 29 and below fall in the very low range. T-scores of 30-39 fall in the low range. T-scores of 40-44 fall in the low average range. T-scores of 45-55 fall in the average range. T-scores of 56-59 fall in the high average range. T-scores of 60-69 fall in the high range. T-scores of 70 and above fall in the very high range.


Secondary Outcome Measures :
  1. Social responsiveness scale [ Time Frame: 15 minutes ]
    A measure of social communication and autism traits. Higher scores indicate a worse outcome. A total T-score of 76 or higher is considered severe and strongly associated with a clinical diagnosis of Autistic Disorder. T-scores of 66 through 75 are interpreted as indicating Moderate deficiencies in reciprocal social behavior that are clinically significant and lead to substantial interference in everyday social interactions. T-scores of 60 to 65 are in the Mild range and indicate mild to moderate deficits in social interaction.T scores of 59 and below are considered to be within typical limits and generally not associated with clinically significant ASD

  2. Social communication questionnaire [ Time Frame: 15 minutes ]
    Measures social communication

  3. Survey for adults [ Time Frame: 10 minutes ]
    Measure of child's physical activity levels and engagement

  4. Survey for children [ Time Frame: 10 minutes ]
    measure of self physical activity levels and engagement



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   4 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Gender Based Eligibility:   Yes
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • There are no inclusion criteria based on gender, pregnancy/childbearing potential, race, ethnicity, or language spoken
  • Children must be between the ages of 4 to 17
  • A diagnosis of a neurodevelopmental disorder

Exclusion Criteria:

  • Children younger than 4 years of age
  • Children older than 17 years of age
  • Children without a neurodevelopmental disorder
  • Children who have previously participated in dance classes held by the Dance program called the Expressive Movement Initiative

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04762290


Contacts
Layout table for location contacts
Contact: Rujuta B Wilson, MD 12085206778 rbhatt@mednet.ucla.edu

Locations
Layout table for location information
United States, California
UCLA David Geffen School of Medicine Recruiting
Los Angeles, California, United States, 90095
Contact: Rujuta B Wilson, MD    208-520-6778    rbhatt@mednet.ucla.edu   
Sponsors and Collaborators
University of California, Los Angeles
Health Resources and Services Administration (HRSA)
Investigators
Layout table for investigator information
Principal Investigator: Rujuta B Wilson, MD UCLA David Geffen School of Medicine
Layout table for additonal information
Responsible Party: Rujuta B. Wilson, MD, Assistant Professor, University of California, Los Angeles
ClinicalTrials.gov Identifier: NCT04762290    
Other Study ID Numbers: 20-001680-AM-00005
First Posted: February 21, 2021    Key Record Dates
Last Update Posted: February 24, 2021
Last Verified: February 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: At this time, there is not a plan to provide confidential individual participant data to other researchers. This study does not entail a medical condition or study of medication for a specific medical or genetic condition.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Neurodevelopmental Disorders
Mental Disorders